Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

Por um escritor misterioso

Descrição

Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Blood pressure control in hypertensive disorders of pregnancy
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Severe Pre-Eclampsia with Partial Hellp Syndrome in Multigravida Preterm Pregnancy
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Effective treatment of hypertension during pregnancy
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
The Lancet on X: NEW Research—Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe #hypertension in #pregnancy: an open-label, randomised controlled trial
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Hypertension during pregnancy: Studies reveal an oral, inexpensive treatment for controlling BP-Health News , Firstpost
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
The Pathogenesis and Treatment of Cardiovascular Autonomic Dysfunction in Parkinson's Disease: What We Know and Where to Go
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Maternal Medicine (Section 4) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Comparative maternal outcomes of oral nifedipine and intravenous labetalol for severe hypertension during pregnancy: an open label randomized controlled trial. - Document - Gale Academic OneFile
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association
Oral antihypertensive regimens (nifedipine retard, labetalol, and  methyldopa) for management of severe hypertension in pregnancy: an  open-label, randomised controlled trial - The Lancet
Effectiveness of nifedipine, labetalol, and
de por adulto (o preço varia de acordo com o tamanho do grupo)